Aneurysm Repair Articles & Analysis
8 news found
Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application to conduct a U.S. trial for the Contour Neurovascular System™, indicated for the treatment of intracranial aneurysms. The IDE approval follows the receipt of Breakthrough Device Designation from the FDA in February 2021. ...
“We are very excited to have access to the ALTO device given its unique approach to excluding the aneurysm using a custom sealing technology, and the higher sealing ring enabled me to land and seal in healthy aortic tissue, which should give this patient a good long-term durable outcome,” Mr. ...
“With both FDA approval and CE Mark, ALTO is an important therapy for physicians and their patients and yet another example of our highly differentiated portfolio of devices aimed at addressing the current unmet needs of endovascular aneurysm repair (EVAR). As we continue to execute our strategy, Endologix is committed to investing in the highest levels of ...
Lastly, CE Mark of the ALTO system is yet another critical milestone for Endologix as we seek to introduce a portfolio of devices to address the current unmet needs of endovascular aneurysm repair (EVAR).” “ALTO offers a highly differentiated endovascular treatment option to AAA patients and includes design features that we believe will enhance ...
The core founding team at Second Heart Assist, Inc. previously developed the world’s leading aortic stent graft system for endovascular aortic aneurysm repair and one of the first patented percutaneous delivered heart valves. ...
The core founding team at Second Heart Assist, Inc. previously developed the world’s leading aortic stent graft system for endovascular aortic aneurysm repair and one of the first patented percutaneous delivered heart valves. ...
In the early 1990s we developed the first stent graft that could be delivered with the percutaneous entry for repairing aortic aneurysms. In 1995 in Australia we completed the first non-surgical repair of an aortic aneurysm. That product has become the leading product in the world for repairing aortic ...
Under the terms of the agreement, CryoLife will have exclusive European distribution rights to NEXUS™, the first off-the-shelf endovascular stent graft system approved for the repair of both aneurysms and dissections in the aortic arch. CryoLife will pay a total upfront payment of $10 million. ...